Study Evaluating Single Ascending Doses Of ILS-920
Clinical trial NCT00827190 · COMPLETED
Trial details
- NCT number
- NCT00827190
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-02-01
- Primary completion
- 2009-07-01
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.